Eyebright Medical(688050) Zheng Quan Zhi Xing·2025-05-29 12:19Core Viewpoint - The company has announced the use of temporarily idle raised funds for cash management, ensuring that it does not affect the normal operation of fundraising investment projects [1][4][5]. Summary by Sections 1. Basic Information on Raised Funds - The company raised a total of RMB 284.61 million through a simplified procedure for issuing shares, with a net amount of RMB 280.61 million after deducting related issuance costs [1][2]. 2. Investment Project Situation - The raised funds will be allocated to projects with a total investment of RMB 422.43 million, with RMB 284.61 million planned for use from the raised funds [2]. 3. Cash Management of Idle Funds - The company plans to use up to RMB 150 million of temporarily idle raised funds for cash management, with a usage period of up to 12 months from the board's approval date [3][4]. - The investment products will include safe and liquid options such as agreement deposits, structured deposits, and large certificates of deposit [3][5]. 4. Impact on Company Operations - The cash management of temporarily idle funds will not affect the company's daily operations or the normal progress of fundraising projects, and it aims to enhance the efficiency of fund utilization [4][5]. 5. Review Procedures - The board and supervisory committee approved the cash management proposal on May 29, 2025, without needing to submit it to the shareholders' meeting [6]. 6. Opinions from Supervisory Committee and Sponsor - The supervisory committee unanimously agreed that the cash management of idle funds would improve fund utilization efficiency without harming shareholder interests [5][6]. - The sponsor confirmed that the proposal complies with relevant regulations and will not affect the normal implementation of fundraising projects [5][6].